• Users Online: 310
  • Print this page
  • Email this page
Year : 2020  |  Volume : 3  |  Issue : 3  |  Page : 445-454

Construction and validation of a quality of life tool for pediatric patients of Indian origin with cancer: A single-center prospective study

1 Department of Psycho Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India
2 Department of Pediatric Oncology/Medical Oncology, Cancer Institute (WIA), Chennai, Tamil Nadu, India

Correspondence Address:
Chindhu Shunmugasundaram
School of Psychology, The University of Sydney, Level 6, Chris O'fBrien Lifehouse, Missenden Road, NSW 2050
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/CRST.CRST_191_20

Get Permissions

Background: Quality of life (QOL) is an important clinical end point in pediatric oncology. The lack of a culture-specific measure to assess the QOL of Indian pediatric patients with cancer has led to this study. Objectives: This study was aimed at constructing and validating a QOL tool for Indian pediatric patients with cancer. Materials and Methods: This was a single-center prospective study conducted at the Cancer Institute, WIA, in Chennai, India, between July and October 2013. The study was conducted in two phases. Phase I consisted of generating and drafting of items, face validity, and field and pilot testing. Phase II involved establishing the validity and reliability of the measure. A total of 264 pediatric cancer patients aged 10–17 years were included for the construction of this measure. Factorial analysis, “t” test, Spearman's product moment correlation, and Cronbach's alpha coefficient were employed for data analysis. Results: A reliable, valid, and internally consistent measure containing 31 items named Cancer Institute Pediatric Oncology Quality of Life Questionnaire-31 (CI-Ped Onc QLQ 31) was developed to assess the QOL of pediatric patients with cancer. The Cronbach's alpha and the Guttman split-half reliability of the developed measure were 0.83 and 0.80, respectively. The four factors that emerged after factor analysis (eigenvalues ranging from 7.495 to 1.495 with 46.53% variance) were grouped into three: “physical well-being,” “psychosocial well-being,” and “treatment-related concerns.” Discriminant validity was established within the gender and treatment status. Conclusions: The CI-Ped Onc QLQ 31 was constructed and validated. It was found to be suitable for pediatric patients of Indian origin with cancer. This measure can be used for screening by health professionals across various spectra, to plan interventions and for future research in the field.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded27    
    Comments [Add]    

Recommend this journal